Site 24

New York, New York 10029

1 studies enrolling now · 2 studies all time

What they study most

Cushing Syndrome, Head and Neck Squamous Cell Carcinoma

Studies at this site

• A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2) — Recruiting now
• Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome — Running, not enrolling